Cardio Dx Inc is categorized under Biotechnology Products and Services in Palo Alto, CA .
Cardio Dx Inc was established in 0, and today employs 1 to 4, earning Unknown per year. This is a Biotechnology Products and Services business, which does work in the B2B market, and is classified as a Biotechnology Products and Services, under code number 5417114 by the NAICS.
If you are seeking more information, feel free to contact David Levison, Chief Executive Officer at the company’s single location by writing to 3183 Porter Drive, Palo Alto, California CA 94304 or by phoning (650) 475-2788. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Cardio Dx Inc |
| Contact Person: | David Levison, Chief Executive Officer |
| Address: | 3183 Porter Drive, Palo Alto, California 94304 |
| Phone Number: | (650) 475-2788 |
| Website Address: | cardiodx.com |
| Annual Revenue (USD): | Unknown |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Biotechnology Products and Services |
| SIC Code: | 8731 |
| NAICS Code: | 5417114 |
| Share This Business: |
Cardio Dx Inc was started in 0 to provide professional Biotechnology Products and Services under the SIC code 8731 and NAICS code 5417114. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact David Levison, Chief Executive Officer for inquiries that concern Cardio Dx Inc by calling the company number (650) 475-2788, as your correspondence is most welcome. Additionally, the physical location of the single location of Cardio Dx Inc can be found at the coordinates 37.40776,-122.14874 as well as the street address 3183 Porter Drive in Palo Alto, California 94304.
For its online presence, you may visit Cardio Dx Inc’s website at cardiodx.com and engage with its social media outlets through on Twitter and on Facebook.